Sariman, M. Et Al. 2023. Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2 , 92-102.

Sariman, M., Salman Yaylaz, B., Yabaci Tak, A., Ayer, M., Sirma Ekmekci, S., Suer, İ., ... Cefle, K.(2023). Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, 92-102.

Sariman, Melda Et Al. "Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma," UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, 92-102, 2023

Sariman, Melda Et Al. "Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, pp.92-102, 2023

Sariman, M. Et Al. (2023) . "Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma." UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.33, no.2, pp.92-102.

@article{article, author={Melda Sariman Et Al. }, title={Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma}, journal={UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi}, year=2023, pages={92-102} }